Investor Senzar Asset Management, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Senzar Asset Management, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2018-02-14 13G/A CORI / Corium International, Inc. 0 0
2018-02-13 13G/A CORI / Corium International, Inc. 1,576,766 0
2017-02-13 13G/A TVTY / Tivity Health Inc 2,525,044 383,200
2017-02-13 13G/A VXRT / Vaxart, Inc. 1,774,876
2017-02-13 13G/A NVRO / Nevro Corp. 1,682,877 0
2017-02-13 13G/A CNCE / Concert Pharmaceuticals Inc 1,432,617 400,588
2017-02-13 13G/A CORI / Corium International, Inc. 1,321,479 1,576,766
2017-02-13 13G/A VXRT / Vaxart, Inc. 2,025,976 1,774,876
2017-02-13 13G/A FOMX / Foamix Pharmaceuticals Ltd. 1,587,931 550,997
2016-02-12 13G/A NVRO / Nevro Corp. 2,441,419 1,682,877
2016-02-12 13G/A CNCE / Concert Pharmaceuticals Inc 963,000 1,432,617
2016-02-12 13G/A SIEN / Sientra, Inc. 1,278,086 580,851
2016-02-12 13G/A CORI / Corium International, Inc. 1,321,479
2016-02-12 13G/A TVTY / Tivity Health Inc 1,828,062 2,525,044
2016-01-15 13G VXRT / Vaxart, Inc. 2,025,976
2016-01-15 13G FOMX / Foamix Pharmaceuticals Ltd. 1,587,931
2015-10-13 13G SIEN / Sientra, Inc. 1,278,086
2015-08-27 13G NVRO / Nevro Corp. 2,441,419
2015-07-28 13G TVTY / Tivity Health Inc 1,828,062
2015-03-09 13G CNCE / Concert Pharmaceuticals Inc 963,000
2015-01-07 13G CORI / Corium International, Inc. 1,040,078